BEAT News and Press, Heartbeam Inc. From 03/07/22

HeartBeam, Inc. (NASDAQ: BEAT), a developmental stage digital healthcare company with a proprietary ECG telemedicine technology for heart attack detection, will hold a conference call on Thursday, March 24, 2022 at 4:30 p.m. Eastern time to discuss its results for the fourth quarter...

Business Associate Agreement and Clinical Trial Agreement with Additional Planned Studies and Commercial and Scientific Collaboration HeartBeam, Inc. (NASDAQ: BEAT), a developmental stage digital healthcare company with a proprietary ECG telemedicine technology for heart...

BioCardia (NASDAQ:BCDA) +32% receives FDA breakthrough device designation for CardiAMP cell therapy system for heart failure. Bon Natural Life (NASDAQ:BON) +29% on FY results. Lightning eMotors (NYSE:ZEV) +19% after electrification deal with General Motors. Redwire (NYSE:RDW) +...

HeartBeam (NASDAQ:BEAT) is collaborating with LIVMOR to build a HeartBeam branded version of LIVMOR’s Halo+ FDA cleared turnkey solution for remote patient monitoring (RPM) to connect physicians and patients. Under the terms of the agreement, LIVMOR will develop  a ...

LIVMOR to Develop HeartBeam Branded Version of the FDA Registered LIVMOR Halo+ Portal HeartBeam, Inc . (NASDAQ: BEAT), a developmental stage digital healthcare company with a proprietary ECG telemedicine technology for heart attack detection, today announced it has signe...

HeartBeam, Inc. (NASDAQ: BEAT), a developmental stage digital healthcare company with a proprietary ECG telemedicine technology to bring new capabilities to cardiovascular disease, today announced the establishment of a Scientific Advisory Board (SAB) to provide scientific guidance ...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips One of the reasons why people have gravitated toward benchmark cryptocurrencies is that their supply tends to be deflationary. That is, despite ravenous demand for popular cryptos, their supply — controlled by a dece...

Point Roberts, WA and Delta, BC - January 7, 2022 (Investorideas.com Newswire) Investorideas.com , a global news source and expert investing resource, announces its weekly roundup of stocks to watch in Mining, Cannabis and Tech. Today's stocks have been added to our lists of free stock ...

HeartBeam, Inc . (NASDAQ: BEAT), a developmental stage digital healthcare company with a proprietary ECG telemedicine technology to bring new capabilities to cardiovascular disease, announced today it will participate in the H.C. Wainwright BIOCONNECT Conference being held virtually...

HeartBeam (NASDAQ:BEAT) names Alan Baumel as COO Before joining HeartBeam, Mr. Baumel was Program Director of the Case for Quality Collaborative Community at Medical Device Innovation Consortium. For further details see: Alan Baumel is the new COO at HeartBeam